Inglebert, M.; Dettwiler, M.; He, C.; Markkanen, E.; Opitz, L.; Naguleswaran, A.; Rottenberg, S.
Individualized Pooled CRISPR/Cas9 Screenings Identify CDK2 as a Druggable Vulnerability in a Canine Mammary Carcinoma Patient. Vet. Sci. 2025, 12, 183.
https://doi.org/10.3390/vetsci12020183
AMA Style
Inglebert M, Dettwiler M, He C, Markkanen E, Opitz L, Naguleswaran A, Rottenberg S.
Individualized Pooled CRISPR/Cas9 Screenings Identify CDK2 as a Druggable Vulnerability in a Canine Mammary Carcinoma Patient. Veterinary Sciences. 2025; 12(2):183.
https://doi.org/10.3390/vetsci12020183
Chicago/Turabian Style
Inglebert, Marine, Martina Dettwiler, Chang He, Enni Markkanen, Lennart Opitz, Arunasalam Naguleswaran, and Sven Rottenberg.
2025. "Individualized Pooled CRISPR/Cas9 Screenings Identify CDK2 as a Druggable Vulnerability in a Canine Mammary Carcinoma Patient" Veterinary Sciences 12, no. 2: 183.
https://doi.org/10.3390/vetsci12020183
APA Style
Inglebert, M., Dettwiler, M., He, C., Markkanen, E., Opitz, L., Naguleswaran, A., & Rottenberg, S.
(2025). Individualized Pooled CRISPR/Cas9 Screenings Identify CDK2 as a Druggable Vulnerability in a Canine Mammary Carcinoma Patient. Veterinary Sciences, 12(2), 183.
https://doi.org/10.3390/vetsci12020183